Open AccessP920: EFFECTIVENESS AND SAFETY OF SELINEXOR‐BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL‐WORLD STUDY FROM CHINA
Author(s) -
Kuang L.,
Fang B.,
Chen W.,
Liu A.,
Li C.,
Bao L.,
Fu C.,
Chen J.,
Li H.,
Pang Y.,
Liao A.,
Liang Y.,
Wei Y.,
Li J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846548.89204.ce
Subject(s) - medicine , multiple myeloma , regimen , daratumumab , oncology , refractory (planetary science) , adverse effect , lenalidomide , physics , astrobiology